IRLA — IRulya Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for IRulya Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	107	90.2	75.1	40.8	17.8
Net Total Receivables	—	—	—	—	3.62
Prepaid Expenses
Total Other Current Assets
Total Current Assets	112	93.7	77.4	44	22.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.43	0.684	0.619	0.813	1.05
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	133	104	168	114	93.5
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14.2	3.07	9.57	7.28	43.2
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	14.6	3.32	82.8	84.3	129
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	119	101	85.1	30.1	-35.7
Total Liabilities & Shareholders' Equity	133	104	168	114	93.5
Total Common Shares Outstanding